These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

733 related items for PubMed ID: 16750294

  • 1. Efficacy and safety of a single botulinum type A toxin complex treatment (Dysport) for the relief of upper back myofascial pain syndrome: results from a randomized double-blind placebo-controlled multicentre study.
    Göbel H, Heinze A, Reichel G, Hefter H, Benecke R, Dysport myofascial pain study group.
    Pain; 2006 Nov; 125(1-2):82-8. PubMed ID: 16750294
    [Abstract] [Full Text] [Related]

  • 2. Botulinum type A toxin complex for the relief of upper back myofascial pain syndrome: how do fixed-location injections compare with trigger point-focused injections?
    Benecke R, Heinze A, Reichel G, Hefter H, Göbel H, Dysport myofascial pain study group.
    Pain Med; 2011 Nov; 12(11):1607-14. PubMed ID: 21692970
    [Abstract] [Full Text] [Related]

  • 3. Botulinum toxin a in the treatment of chronic tension-type headache with cervical myofascial trigger points: a randomized, double-blind, placebo-controlled pilot study.
    Harden RN, Cottrill J, Gagnon CM, Smitherman TA, Weinland SR, Tann B, Joseph P, Lee TS, Houle TT.
    Headache; 2009 May; 49(5):732-43. PubMed ID: 19178577
    [Abstract] [Full Text] [Related]

  • 4. [Botulinum toxin treatment of hip adductor spasticity in multiple sclerosis].
    Wissel J, Entner T.
    Wien Klin Wochenschr; 2001 May; 113 Suppl 4():20-4. PubMed ID: 15506048
    [Abstract] [Full Text] [Related]

  • 5. Long-term efficacy and safety of botulinum toxin type A (Dysport) in cervical dystonia.
    Truong D, Brodsky M, Lew M, Brashear A, Jankovic J, Molho E, Orlova O, Timerbaeva S, Global Dysport Cervical Dystonia Study Group.
    Parkinsonism Relat Disord; 2010 Jun; 16(5):316-23. PubMed ID: 20359934
    [Abstract] [Full Text] [Related]

  • 6. Efficacy and safety of botulinum type A toxin (Dysport) in cervical dystonia: results of the first US randomized, double-blind, placebo-controlled study.
    Truong D, Duane DD, Jankovic J, Singer C, Seeberger LC, Comella CL, Lew MF, Rodnitzky RL, Danisi FO, Sutton JP, Charles PD, Hauser RA, Sheean GL.
    Mov Disord; 2005 Jul; 20(7):783-91. PubMed ID: 15736159
    [Abstract] [Full Text] [Related]

  • 7. A double-blind, controlled study of botulinum toxin A in chronic myofascial pain.
    Qerama E, Fuglsang-Frederiksen A, Kasch H, Bach FW, Jensen TS.
    Neurology; 2006 Jul 25; 67(2):241-5. PubMed ID: 16864815
    [Abstract] [Full Text] [Related]

  • 8. Botulinum toxin type a for the prophylaxis of chronic daily headache: subgroup analysis of patients not receiving other prophylactic medications: a randomized double-blind, placebo-controlled study.
    Dodick DW, Mauskop A, Elkind AH, DeGryse R, Brin MF, Silberstein SD, BOTOX CDH Study Group.
    Headache; 2005 Apr 25; 45(4):315-24. PubMed ID: 15836567
    [Abstract] [Full Text] [Related]

  • 9. Intra-articular botulinum toxin A for refractory shoulder pain: a randomized, double-blinded, placebo-controlled trial.
    Singh JA, Mahowald ML, Noorbaloochi S.
    Transl Res; 2009 May 25; 153(5):205-16. PubMed ID: 19375681
    [Abstract] [Full Text] [Related]

  • 10. Therapeutic use of botulinum toxin type A in treating neck and upper-back pain of myofascial origin: a pilot study.
    Lew HL, Lee EH, Castaneda A, Klima R, Date E.
    Arch Phys Med Rehabil; 2008 Jan 25; 89(1):75-80. PubMed ID: 18164334
    [Abstract] [Full Text] [Related]

  • 11. The analgesic effect of botulinum-toxin A on postwhiplash neck pain.
    Braker C, Yariv S, Adler R, Badarny S, Eisenberg E.
    Clin J Pain; 2008 Jan 25; 24(1):5-10. PubMed ID: 18180629
    [Abstract] [Full Text] [Related]

  • 12. Botulinum toxin type a prophylactic treatment of episodic migraine: a randomized, double-blind, placebo-controlled exploratory study.
    Aurora SK, Gawel M, Brandes JL, Pokta S, Vandenburgh AM, BOTOX North American Episodic Migraine Study Group.
    Headache; 2007 Apr 25; 47(4):486-99. PubMed ID: 17445098
    [Abstract] [Full Text] [Related]

  • 13. Injection in the cervical facet joint for shoulder pain with myofascial trigger points in the upper trapezius muscle.
    Tsai CT, Hsieh LF, Kuan TS, Kao MJ, Hong CZ.
    Orthopedics; 2009 Aug 25; 32(8):. PubMed ID: 19708635
    [Abstract] [Full Text] [Related]

  • 14. Efficacy and safety of 3- and 5-injection patterns (30 and 50 U) of botulinum toxin A (Dysport) for the treatment of wrinkles in the glabella and the central forehead region.
    Rzany B, Ascher B, Fratila A, Monheit GD, Talarico S, Sterry W.
    Arch Dermatol; 2006 Mar 25; 142(3):320-6. PubMed ID: 16549707
    [Abstract] [Full Text] [Related]

  • 15. Are the effects of botulinum toxin injection on myofascial trigger points placebo effects or needling effects?
    Hsieh RL, Lee WC.
    Arch Phys Med Rehabil; 2008 Apr 25; 89(4):792-3; author reply 793. PubMed ID: 18374016
    [No Abstract] [Full Text] [Related]

  • 16. Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues.
    Cady R, Schreiber C.
    Headache; 2008 Jun 25; 48(6):900-13. PubMed ID: 18047501
    [Abstract] [Full Text] [Related]

  • 17. Botulinum toxin A versus bupivacaine trigger point injections for the treatment of myofascial pain syndrome: a randomised double blind crossover study.
    Graboski CL, Gray DS, Burnham RS.
    Pain; 2005 Nov 25; 118(1-2):170-5. PubMed ID: 16202527
    [Abstract] [Full Text] [Related]

  • 18. A randomized, controlled study comparing a lidocaine patch, a placebo patch, and anesthetic injection for treatment of trigger points in patients with myofascial pain syndrome: evaluation of pain and somatic pain thresholds.
    Affaitati G, Fabrizio A, Savini A, Lerza R, Tafuri E, Costantini R, Lapenna D, Giamberardino MA.
    Clin Ther; 2009 Apr 25; 31(4):705-20. PubMed ID: 19446144
    [Abstract] [Full Text] [Related]

  • 19. The efficacy of topical thiocolchicoside (Muscoril) in the treatment of acute cervical myofascial pain syndrome: a single-blind, randomized, prospective, phase IV clinical study.
    Ketenci A, Basat H, Esmaeilzadeh S.
    Agri; 2009 Jul 25; 21(3):95-103. PubMed ID: 19780000
    [Abstract] [Full Text] [Related]

  • 20. A prospective randomized controlled study of the role of botulinum toxin in whiplash-associated disorder.
    Carroll A, Barnes M, Comiskey C.
    Clin Rehabil; 2008 Jun 25; 22(6):513-9. PubMed ID: 18511531
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 37.